Pfizer decides to withdraw emergency use authorisation application in India

05 Feb 2021 Evaluate

Pfizer has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India. Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.
 
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4765.15 -53.70 (-1.11%)
11-Mar-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1822.60
Dr. Reddys Lab 1326.05
Cipla 1327.20
Zydus Lifesciences 930.00
Lupin 2360.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×